Korean Companies Occupying South Korea’s Diverse Biotech Landscape
In face of the COVID-19 pandemic, South Korea’s biotech companies have risen to the challenge of supplying the world’s vaccines, and the region is on the path to becoming one of the leading biologics manufacturers. The Korean government is actively introducing policies that favor biotech developments, such as supporting businesses to invest up to 65% of their net revenue in pharmaceutical R&Ds.
It's free! Log in now to read